A bill to eliminate the requirement that veterans pay a copayment to the Department of Veterans Affairs to receive opioid antagonists or education on the use of opioid antagonists.

1/11/2023, 1:31 PM

This bill exempts from the requirement that veterans pay a Department of Veterans Affairs copayment for:

  • any opioid antagonists furnished to a veteran at high risk for overdose of a specific medication or substance in order to reverse the effect of such an overdose, and
  • education on their use.
Congress
114
Number
S - 2772
Introduced on
2016-04-11
# Amendments
0
Sponsors
+5
Cosponsors
+5

Variations and Revisions

4/11/2016
Text
PDF
XML

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

This bill exempts from the requirement that veterans pay a Department of Veterans Affairs copayment for:

  • any opioid antagonists furnished to a veteran at high risk for overdose of a specific medication or substance in order to reverse the effect of such an overdose, and
  • education on their use.
Alternative Names
Official Title as IntroducedA bill to eliminate the requirement that veterans pay a copayment to the Department of Veterans Affairs to receive opioid antagonists or education on the use of opioid antagonists.
Policy Areas
Armed Forces and National Security
Potential Impact
Drug therapy•
Drug trafficking and controlled substances•
Health promotion and preventive care•
Home and outpatient care•
Veterans' medical care

Comments

Related

Bill Update Alert:  Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017

Recent Activity

Latest Summary4/14/2016

This bill exempts from the requirement that veterans pay a Department of Veterans Affairs copayment for:

  • any opioid antagonists furnished to a veteran at high risk for overdose of a specific medication or substance in order to revers...
Latest Action4/11/2016
Read twice and referred to the Committee on Veterans' Affairs.